Vir Biotechnology (VIR) Long-Term Investments (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Long-Term Investments data on file, last reported at $333.0 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 52.64% year-over-year to $333.0 million; the trailing twelve-month figure through Mar 2026 stood at $333.0 million (up 52.64% YoY), and the FY2025 full-year result was $314.6 million, up 65.55% from the prior year.
• Long-Term Investments climbed to $333.0 million in Q1 2026, from $314.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $359.7 million in Q1 2024 to a low of $23.9 million in Q4 2022.
• A 5-year average of $180.2 million and a median of $190.0 million in 2024 frame the typical range for Long-Term Investments.
• Peak annual rise in Long-Term Investments reached 1612.02% in 2022, while the deepest fall reached 88.12% in 2022.
• Tracing VIR's Long-Term Investments over 5 years: stood at $23.9 million in 2022, then jumped by 339.98% to $105.3 million in 2023, then surged by 80.49% to $190.0 million in 2024, then jumped by 65.55% to $314.6 million in 2025, then increased by 5.85% to $333.0 million in 2026.
• Business Quant data shows VIR's Long-Term Investments at $333.0 million in Q1 2026, $314.6 million in Q4 2025, and $304.2 million in Q3 2025.